SEC 13F Intelligence

Managers / Q4 2018 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$186M
Q4 2018
Positions
48
Filings on Record
30
2019–present window
Filed
Feb 12, 2019
original filing

Summary

Sivik Global Healthcare LLC reported $186M in U.S.-listed holdings across 48 positions for Q4 2018.

Its largest position, ABT, represents 4.5% of the portfolio.

Portfolio Metrics

Top-10 Concentration
+37.9%
share of reported value
Largest Position
+4.5%
Abbott Laboratories

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 87.2%ADR: 6.1%Other: 3.8%ETP: 2.9%
  • Common Stock · 87.2% · $162M
  • ADR · 6.1% · $11M
  • Other · 3.8% · $7M
  • ETP · 2.9% · $5M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
ABTABBOTT LABORATORIESNEW+115.0K115.0K+$8M$8M
BSXBOSTON SCIENTIFIC CORP COM STKNEW+220.0K220.0K+$8M$8M
WELLCARE HEALTH PLANS INC COM STKNEW+32.5K32.5K+$8M$8M
CICIGNA CORPORATION COM STKNEW+40.0K40.0K+$8M$8M
MRKMERCK & CONEW+95.0K95.0K+$7M$7M
UNHUNITEDHEALTH GROUP INCNEW+28.0K28.0K+$7M$7M
ISRGINTUITIVE SURGICAL INCNEW+13.5K13.5K+$6M$6M
LLYELI LILLY & CONEW+55.0K55.0K+$6M$6M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2018

48 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ABTABBOTT LABORATORIEShistory →Cash Securities4.48%$8M115.0K
2BSXBOSTON SCIENTIFIC CORP COM STKhistory →Cash Securities4.19%$8M220.0K
3WELLCARE HEALTH PLANS INC COM STKCash Securities4.14%$8M32.5K
4CICIGNA CORPORATION COM STKhistory →Cash Securities4.09%$8M40.0K
5MRKMERCK & COhistory →Cash Securities3.91%$7M95.0K
6UNHUNITEDHEALTH GROUP INChistory →Cash Securities3.76%$7M28.0K
7ISRGINTUITIVE SURGICAL INChistory →Cash Securities3.48%$6M13.5K
8LLYELI LILLY & COhistory →Cash Securities3.43%$6M55.0K
9BIIBBIOGEN INC COM STKhistory →Cash Securities3.24%$6M20.0K
10ELVANTHEM INC COM STKhistory →Cash Securities3.19%$6M22.5K
11VRTXVERTEX PHARMACEUTICALS INC COM STKhistory →Cash Securities3.13%$6M35.0K
12HUMHUMANA INC COM STKhistory →Cash Securities3.09%$6M20.0K
13SYKSTRYKER CORP COMhistory →Cash Securities2.96%$5M35.0K
14XBISPDR S&P BIOTECH ETFhistory →Cash Securities2.90%$5M75.0K
15AZNNASTRAZENECA PLC ADRhistory →Cash Securities2.77%$5M135.4K
16BMRNBIOMARIN PHARMACEUTICAL INC COM STKhistory →Cash Securities2.52%$5M55.0K
17UHSUNIVERSAL HEALTH SERVICES INC CL Bhistory →Cash Securities2.51%$5M40.0K
18DHRDANAHER CORP COM STKhistory →Cash Securities2.50%$5M45.0K
19ILMNILLUMINA INC COM STKhistory →Cash Securities2.43%$4M15.0K
20HCAHCA HEALTHCARE INChistory →Cash Securities2.35%$4M35.0K
21WRIGHT MEDICAL GROUPNV COM STKCash Securities2.17%$4M147.8K
22BAXBAXTER INTL INC COM STKhistory →Cash Securities2.13%$4M60.0K
23QGENQIAGEN N.V. COM STKhistory →Cash Securities2.06%$4M110.8K
24LHC GROUP INC COM STKCash Securities2.02%$4M40.0K
25REGNREGENERON PHARMACEUTICALS INChistory →Cash Securities2.01%$4M10.0K
26MOHMOLINA HEALTHCARE INC COM STKhistory →Cash Securities1.88%$3M30.0K
27CNCCENTENE CORP DEL COM STKhistory →Cash Securities1.83%$3M29.4K
28TMOTHERMO FISHER CORPhistory →Cash Securities1.81%$3M15.0K
29AAGILENT TECHNOLOGIES INC COM STKhistory →Cash Securities1.71%$3M47.1K
30BIOBIO-RAD LABORATORIES INC CL A COM STKhistory →Cash Securities1.56%$3M12.5K
31TEVATEVA PHARMhistory →Cash Securities1.54%$3M185.0K
32SNNSMITH & NEPHEW PLC ADRhistory →Cash Securities1.53%$3M76.0K
33BHCBAUSCH HEALTH COS INC COM STKhistory →Cash Securities1.49%$3M150.0K
34ELANELANCO ANIMAL HEALTH INChistory →Cash Securities1.42%$3M83.6K
35AMEDAMEDISYS INC COM STKhistory →Cash Securities1.26%$2M20.0K
36INCYINCYTE CORP COM STKhistory →Cash Securities1.20%$2M35.0K
37SRPTSAREPTA THERAPUTICS INChistory →Cash Securities1.18%$2M20.0K
38ZBHZIMMER HOLDINGS INC COM STKhistory →Cash Securities1.12%$2M20.0K
39MCKMCKESSON CORP COM STKCash Securities0.89%$2M15.0K
40MYLAN NVCash Securities0.83%$2M56.2K
41LOXO ONCOLOGY INCCash Securities0.76%$1M10.0K
42SAGE THERAPEUTICS INC CAMBRID COM STKCash Securities0.52%$958,00010.0K
43DXCMDEXCOM INC COM STKCash Securities0.48%$899,0007.5K
44CORAMERISOURCEBERGEN CORP COM STKCash Securities0.40%$744,00010.0K
45AGIOAGIOS PHARMACash Securities0.37%$692,00015.0K
46HAEHAEMONETICS CORP COM STKCash Securities0.27%$500,0005.0K
47GW PHRMA PLCCash Securities0.26%$487,0005.0K
48MRNAMODERNA INCCash Securities0.21%$382,00025.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.